1. Home
  2. IRON vs NYAX Comparison

IRON vs NYAX Comparison

Compare IRON & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$68.20

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Nayax Ltd.

NYAX

Nayax Ltd.

HOLD

Current Price

$70.68

Market Cap

2.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
NYAX
Founded
2017
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.5B
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
IRON
NYAX
Price
$68.20
$70.68
Analyst Decision
Strong Buy
Buy
Analyst Count
11
4
Target Price
$103.18
$49.50
AVG Volume (30 Days)
426.0K
29.1K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.66
Revenue Next Year
$283.52
$21.70
P/E Ratio
N/A
$89.78
Revenue Growth
N/A
N/A
52 Week Low
$40.00
$39.17
52 Week High
$99.50
$75.00

Technical Indicators

Market Signals
Indicator
IRON
NYAX
Relative Strength Index (RSI) 51.91 59.49
Support Level $58.13 $51.53
Resistance Level $71.53 $74.83
Average True Range (ATR) 3.23 2.74
MACD -0.17 -0.39
Stochastic Oscillator 46.09 63.91

Price Performance

Historical Comparison
IRON
NYAX

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It unifies payments, operations management, and customer engagement tools into a powerful, adaptable platform for modern commerce. It provides solutions that empower businesses to enhance customer experience, accept cashless payments, and manage their operations with a robust Internet of Things (IoT) software platform, helping achieve long-term growth. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

Share on Social Networks: